5 Key Takeaways
-
1
Sheraz Daya advocates DALK because it replaces diseased anterior corneal tissue while preserving a normal endothelial cell layer.
-
2
Daya cited UK registry data showing a 7% risk of rejection and failure within 3 years after full-thickness grafting for keratoconus.
-
3
Daya said DALK preserves the posterior cornea and avoids endothelial cell loss that can cause full-thickness grafts to fail over time.
-
4
DALK is closed-system surgery, whereas penetrating keratoplasty opens the eye and carries risks including expulsive hemorrhage, infection, and glaucoma.
-
5
DALK use is increasing globally, but the United States performs about 900 to 1,000 cases annually despite an estimated 40,000 eligible cases.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







